COUR Pharmaceuticals
PrivateLast Round
Series B
Jun 18, 2026
Total Funding Raised
$155M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
COUR Pharmaceuticals is a clinical-stage biotechnology company that develops antigen-specific immune tolerance therapies to treat autoimmune and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
COUR Pharmaceuticals Comparables
Compare COUR Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Imcyse | 86% | |
| Anokion | 85% | |
| Topas Therapeutics | 84% | |
COUR Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 18, 2026 | ||||
| Series A | Jan 30, 2024 | ||||
| VC Round | Sep 7, 2022 |
COUR Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Roche Venture Fund | Series A, Series B |
| Roche Venture Fund | Series A |
| Angelini Ventures | Series B, Series A |
| JDRF | Series A, Series B |
| Lumira Ventures | Series A, Series B |
| Pfizer | Series A |
| Chimera Capital Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
$50M round led by Lumira Ventures and Roche Venture Fund.
COUR Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about COUR Pharmaceuticals's valuation, stock price, and market status.